Skip to main content

Table 1 Baseline characteristics of the 21 patients with a CRT-D/P (n = 21)

From: Effects of adaptive left bundle branch–optimized cardiac resynchronization therapy: a single centre experience

 

Total (n = 21)

Group 1 (n = 10)

Group 2 (n = 11)

P value

Age (years)

69.1 ± 6.4

71.8 ± 5.1

66.8 ± 6.9

0.217

Sex, Male, n (%)

9 (42.9%)

4 (40.0%)

5 (45.5%)

1.000

Diabetes mellitus, n (%)

4 (19.0%)

2 (20.0%)

2 (18.2%)

1.000

Hypertension, n (%)

10 (47.6%)

5 (50.0%)

5 (45.5%)

1.000

Frequent VPC, n (%)

6 (28.6%)

2 (20.0%)

4 (36.4%)

0.730

ICM, n (%)

11 (52.4%)

6 (60.0%)

5 (45.5%)

0.819

PCI, n (%)

11 (52.4%)

6 (60.0%)

5 (45.5%)

0.819

NT-proBNP (pg/ml)

2937 ± 1646

3240 ± 2258

2684 ± 1083

0.634

LVEF (%)

33.1 ± 3.0

32.0 ± 4.2

34.0 ± 1.3

0.302

PAF, n (%)

7 (33.3%)

4 (40.0%)

3 (27.3%)

0.877

  1. NT-proBNP N-terminal pro B type brain natriuretic peptide, LVEF left ventricular ejection fraction, PCI percutaneous transluminal coronary intervention, VPC ventricular premature contraction, PAF paroxysmal atrial fibrillation, ICM ischaemic cardiomyopathy